MedTrace Logo

Clinical and Radio-graphic Evaluation of Non-staining Bio-active Bio-ceramic (Neo MTA 2) in Revascularization

NCT06637761 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2024-10-15

No results posted yet for this study

Summary

The study will compare the clinical and radio-graphic performance of newly introduced non-staining bio-active bio-ceramic (Neo MTA 2) versus White MTA used as coronal plug material in revascularization of non-vital immature permanent anterior teeth.Visual examination, palpation, A measuring scale in digital radio-graph software (DIGORA for Windows software) will be used for evaluation.

Conditions

  • Mineral Trioxide Aggregate

Interventions

DRUG

NeoMTA2

Bio-active bio-ceramic mineral trioxide aggregate

DRUG

WMTA

White Mineral trioxide aggregates

Sponsors & Collaborators

  • Misr University for Science and Technology

    collaborator OTHER

  • Cairo University

    lead OTHER

Principal Investigators

  • Youssef · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-05
Primary Completion
2025-10-06
Completion
2025-12-30
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06637761 on ClinicalTrials.gov